Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-15 1:19 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Western Standard LLC | 424,080 6.6% | 41,507 (+10.85%) | View |
| 2022-11-28 4:07 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Western Standard LLC | 382,573 6% | 382,573 (New Position) | View |
| 2022-06-17 4:53 pm Sale | 13D | OPIANT PHARMACEUTICALS INC OPNT | CRYSTAL ROGER | 636,594 11.2% | -96,881 (-13.21%) | View |
| 2022-06-17 4:52 pm Sale | 13D | OPIANT PHARMACEUTICALS INC OPNT | Sinclair Michael | 515,170 9.3% | -230,000 (-30.87%) | View |
| 2022-02-11 09:32 am Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | RENAISSANCE TECHNOLOGIES LLC | 183,815 3.89% | -53,000 (-22.38%) | View |
| 2022-01-27 10:12 am Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | WELLS FARGO & COMPANY WFC | 224,297 4.75% | -27,908 (-11.07%) | View |
| 2021-02-16 2:28 pm Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | Radoff Bradley Louis | 18,000 1% | -259,500 (-93.51%) | View |
| 2021-02-12 5:08 pm Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | Stonepine Capital Management LLC | 0 0% | -334,272 (Position Closed) | View |
| 2021-02-11 4:37 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | WELLS FARGO & COMPANY WFC | 252,205 5.92% | 252,205 (New Position) | View |
| 2021-02-11 2:04 pm Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | Altium Capital Management LP | 0 0% | -349,846 (Position Closed) | View |
| 2021-02-10 4:09 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | RENAISSANCE TECHNOLOGIES LLC | 236,815 5.56% | 236,815 (New Position) | View |
| 2020-02-14 3:46 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Altium Capital Management LP | 349,846 8.5% | 96,973 (+38.35%) | View |
| 2020-02-14 2:06 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Radoff Bradley Louis | 277,500 6.8% | 10,000 (+3.74%) | View |
| 2020-02-13 4:52 pm Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | Stonepine Capital Management LLC | 334,272 8.2% | -23,688 (-6.62%) | View |
| 2020-02-06 4:14 pm Sale | 13D | OPIANT PHARMACEUTICALS INC OPNT | OPIANT PHARMACEUTICALS INC. OPNT | 587,325 12.3% | -127,845 (-17.88%) | View |
| 2020-02-06 4:10 pm Purchase | 13D | OPIANT PHARMACEUTICALS INC OPNT | OPIANT PHARMACEUTICALS INC. OPNT | 715,170 15% | 715,170 (New Position) | View |
| 2019-07-08 12:06 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Radoff Bradley Louis | 267,500 6.7% | 267,500 (New Position) | View |
| 2019-06-05 10:30 am Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Altium Capital Management LP | 252,873 6.3% | 252,873 (New Position) | View |